The mortality of pancreas malignant neoplasms in Brazil is forecasted to increase from 7.09 thousand female deaths in 2024 to 8.06 thousand by 2028. Compared to 2023 data, these values show a consistent upward trend, with year-on-year percentage increases of approximately 3-4%. Over a five-year period from 2024 to 2028, the compound annual growth rate (CAGR) suggests an average annual rise of about 3.25%, indicating a potential public health challenge if these trends continue.
Future trends to watch for include advancements in early detection and treatment options, changing lifestyles, and population aging, which could influence mortality rates. Healthcare policy responses and resource allocation will be critical in managing this growing health issue.
